Purpose: To evaluate treatment options for candida keratitis and endopthalmitis after corneal transplantation.
Methods: Case reports and literature review.
Results: Two patients with keratitis due to / after corneal transplantation were successfully treated with a combination of topical voriconazole, intracameral voriconazole and amphotericin B, and systemic treatment with flucytosine.
Conclusions: Natamycine and voriconazole topically are preferred therapeutic options for the treatment of fungal keratitis. Systemic flucytosine is a useful alternative additive, particularly for countries where natamycine is not registered as a pharmaceutical agent.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999277 | PMC |
http://dx.doi.org/10.1177/11206721211060140 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!